Business Context and Reporting Period
This Form 8-K Current Report was filed by Amneal Pharmaceuticals, Inc. on December 7, 2018, reporting events occurring on December 5, 2018. The filing announces the scheduling of the company's first annual meeting of stockholders.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance events and does not contain financial performance data.
Material Changes
There are no material financial changes reported in this document. The primary event is the determination by the Board of Directors to hold the first annual meeting of stockholders on May 6, 2019. The specific time and location are to be specified in the upcoming proxy statement.
Guidance, Outlook, and Corporate Governance
- Annual Meeting: Scheduled for May 6, 2019.
- Proxy Proposals: Stockholders wishing to submit proposals for inclusion in the 2019 proxy statement must deliver them to the Secretary by January 14, 2019.
- Director Nominations and Other Business: Under the company's bylaws, stockholders must deliver notice of nominations or other business proposals between January 6, 2019 and February 5, 2019.
- Bylaws Reference: A copy of the bylaws was previously filed as Exhibit 3.2 to the Form 10-Q for the quarter ended June 30, 2018.
Key Facts for Investor Verification
- Verify the specific time and location of the annual meeting once the proxy statement is released.
- Confirm the deadline of January 14, 2019, for submitting proposals for inclusion in the proxy statement.
- Note the strict window (January 6 to February 5, 2019) for submitting director nominations or other business proposals not included in the proxy statement.
- Review the company's bylaws (available via the Secretary's office or prior 10-Q filing) for detailed procedural requirements.